Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 264

1.

Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation.

Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ.

Depress Anxiety. 1999;9(4):163-8.

PMID:
10431681
[PubMed - indexed for MEDLINE]
2.

Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients.

van den Broek KC, Nyklícek I, van der Voort PH, Alings M, Meijer A, Denollet J.

J Am Coll Cardiol. 2009 Aug 4;54(6):531-7. doi: 10.1016/j.jacc.2009.04.043.

PMID:
19643315
[PubMed - indexed for MEDLINE]
Free Article
3.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

PMID:
19506335
[PubMed - indexed for MEDLINE]
Free Article
4.

Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.

Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C.

Arch Gen Psychiatry. 2008 Nov;65(11):1324-30. doi: 10.1001/archpsyc.65.11.1324.

PMID:
18981344
[PubMed - indexed for MEDLINE]
5.

Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.

Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA.

Am Heart J. 2005 Apr;149(4):664-9.

PMID:
15990750
[PubMed - indexed for MEDLINE]
6.

Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study.

Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA.

Europace. 2003 Oct;5(4):381-9.

PMID:
14753636
[PubMed - indexed for MEDLINE]
Free Article
7.

Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.

Steinberg JS, Martins J, Sadanandan S, Goldner B, Menchavez E, Domanski M, Russo A, Tullo N, Hallstrom A; AVID Investigators.

Am Heart J. 2001 Sep;142(3):520-9.

PMID:
11526368
[PubMed - indexed for MEDLINE]
8.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

PMID:
16904046
[PubMed - indexed for MEDLINE]
Free Article
9.

Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.

Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S, Lurie KG, Lu F, Benditt DG.

J Am Coll Cardiol. 2005 Dec 20;46(12):2258-63.

PMID:
16360055
[PubMed - indexed for MEDLINE]
Free Article
10.

Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.

Otmani A, Trinquart L, Marijon E, Lavergne T, Waintraub X, Lepillier A, Chatellier G, Le Heuzey JY; EVADEF investigators.

Am Heart J. 2009 Aug;158(2):230-237.e1. doi: 10.1016/j.ahj.2009.05.019.

PMID:
19619699
[PubMed - indexed for MEDLINE]
11.

Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation.

Ptaszek LM, Wang PJ, Hunt SA, Valantine H, Perlroth M, Al-Ahmad A.

Heart Rhythm. 2005 Sep;2(9):931-3.

PMID:
16171746
[PubMed - indexed for MEDLINE]
12.

Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.

Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP.

J Cardiovasc Electrophysiol. 2006 May;17(5):486-90.

PMID:
16684019
[PubMed - indexed for MEDLINE]
13.

Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.

Hallstrom AP, McAnulty JH, Wilkoff BL, Follmann D, Raitt MH, Carlson MD, Gillis AM, Shih HT, Powell JL, Duff H, Halperin BD; Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.

J Am Coll Cardiol. 2001 Mar 15;37(4):1093-9.

PMID:
11263614
[PubMed - indexed for MEDLINE]
Free Article
14.
15.

Mood disturbance in patients with recurrent ventricular dysrhythmia before insertion of implantable cardioverter defibrillator.

Dunbar SB, Jenkins LS, Hawthorne M, Porter LS.

Heart Lung. 1996 Jul-Aug;25(4):253-61.

PMID:
8836741
[PubMed - indexed for MEDLINE]
16.

Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?

Russo AM, Nayak H, Verdino R, Springman J, Gerstenfeld E, Hsia H, Marchlinski FE.

Pacing Clin Electrophysiol. 2003 Dec;26(12):2289-95.

PMID:
14675014
[PubMed - indexed for MEDLINE]
17.

Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators.

Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F.

Circulation. 1998 Aug 18;98(7):663-70. Erratum in: Circulation 1998 Dec 8;98(23):2647.

PMID:
9715859
[PubMed - indexed for MEDLINE]
Free Article
18.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
[PubMed - indexed for MEDLINE]
19.

The effects of age on quality of life in implantable cardioverter defibrillator recipients.

Hamilton GA, Carroll DL.

J Clin Nurs. 2004 Feb;13(2):194-200.

PMID:
14723671
[PubMed - indexed for MEDLINE]
20.

Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.

Ermis C, Zhu AX, Vanheel L, Sakaguchi RN, Lurie KG, Lu F, Benditt DG.

Europace. 2007 May;9(5):270-4. Epub 2007 Mar 19.

PMID:
17371804
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk